Williams R J, Kelly E
Department of Pharmacology, School of Medical Sciences, University of Bristol, UK.
Eur J Pharmacol. 1994 Jul 15;268(2):177-86. doi: 10.1016/0922-4106(94)90187-2.
NG108-15 mouse neuroblastoma x rat glioma cells were treated with the prostanoid IP receptor agonist iloprost (1 microM) and the time course of changes in the levels of prostanoid IP receptors, adenylyl cyclase activity, and the alpha-subunit of the stimulatory guanine nucleotide binding regulatory protein, Gs, were measured. Incubation of cells with iloprost produced a biphasic time course of desensitisation of prostanoid IP receptor-activated adenylyl cyclase. Parallel analysis of iloprost-induced loss of membrane Gs alpha, NaF-stimulated adenylyl cyclase and [3H]iloprost binding suggested only monophasic curves, with t0.5 values similar to the initial phase of desensitisation of iloprost-stimulated adenylyl cyclase activity. This suggests that the loss of receptor and Gs alpha occur at the same time and account for the initial period of desensitisation due to iloprost pretreatment. Pretreatment of NG108-15 cells with cholera toxin produced a near complete loss of membrane-associated Gs alpha, but the loss of [3H]iloprost binding due to iloprost treatment was not affected by pretreatment with cholera toxin, suggesting that prostanoid IP receptors can be down-regulated in the absence of any coupling to Gs. The second phase of desensitisation of iloprost-stimulated adenylyl cyclase activity, during which there was no further change in NaF-stimulated adenylyl cyclase or in the membrane levels of Gs alpha, was not due to protein kinase A activation, since elevating intracellular cyclic AMP levels with forskolin did not subsequently decrease iloprost-stimulated adenylyl cyclase activity or [3H]iloprost binding. These results demonstrate that iloprost pretreatment of NG108-15 cells induces two distinct phases of desensitisation; an initial desensitisation due to concurrent loss of prostanoid IP receptors and Gs alpha, and then a further desensitisation by an as yet uncharacterized mechanism during which there is no further loss of Gs alpha.
用前列腺素IP受体激动剂伊洛前列素(1微摩尔)处理NG108 - 15小鼠神经母细胞瘤×大鼠胶质瘤细胞,并测量前列腺素IP受体水平、腺苷酸环化酶活性以及刺激性鸟嘌呤核苷酸结合调节蛋白Gs的α亚基变化的时间进程。用伊洛前列素孵育细胞会使前列腺素IP受体激活的腺苷酸环化酶脱敏呈现双相时间进程。对伊洛前列素诱导的膜Gsα丢失、氟化钠刺激的腺苷酸环化酶以及[³H]伊洛前列素结合进行平行分析,结果显示仅为单相曲线,其t0.5值与伊洛前列素刺激的腺苷酸环化酶活性脱敏的初始阶段相似。这表明受体和Gsα的丢失同时发生,并且是伊洛前列素预处理导致脱敏初期的原因。用霍乱毒素预处理NG108 - 15细胞会使膜相关的Gsα几乎完全丢失,但伊洛前列素处理导致的[³H]伊洛前列素结合的丢失不受霍乱毒素预处理的影响,这表明前列腺素IP受体在未与Gs发生任何偶联的情况下也能被下调。伊洛前列素刺激的腺苷酸环化酶活性脱敏的第二阶段,在此期间氟化钠刺激的腺苷酸环化酶或膜中Gsα水平没有进一步变化,这并非由于蛋白激酶A激活所致,因为用福斯高林提高细胞内环磷酸腺苷水平随后并未降低伊洛前列素刺激的腺苷酸环化酶活性或[³H]伊洛前列素结合。这些结果表明,用伊洛前列素预处理NG108 - 15细胞会诱导两个不同阶段的脱敏;最初的脱敏是由于前列腺素IP受体和Gsα同时丢失,随后是通过一种尚未明确的机制进一步脱敏,在此期间Gsα没有进一步丢失。